Related Experiment Videos

Cefmetazole treatment of intra-abdominal infection

W J Holloway1, D L Winslow, J F Reinhardt

  • 1Infectious Disease Section, Medical Center of Delaware, Wilmington.

Insights

Cefmetazole and cefoxitin showed similar effectiveness and tolerance for treating intra-abdominal infections. A few patients experienced microbiological failure or prothrombin time prolongation with cefmetazole.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Medicine

Background:

  • Intra-abdominal infections are a significant cause of morbidity.
  • Single-agent antibiotic therapy is often preferred for its simplicity.
  • Cefmetazole and cefoxitin are cephalosporin antibiotics with broad-spectrum activity.

Purpose of the Study:

  • To compare the efficacy and safety of cefmetazole versus cefoxitin as single-agent therapy for intra-abdominal infections.
  • To evaluate clinical response, microbiological outcomes, and adverse events associated with each antibiotic.

Main Methods:

  • Prospective study enrolling 79 patients with intra-abdominal infections.
  • Patients received either cefmetazole or cefoxitin as single-agent antibiotic therapy.
  • Infections included appendicitis, perforated peptic ulcer, and other processes.

Main Results:

  • Both cefmetazole and cefoxitin demonstrated good clinical response rates.
  • Patient tolerance was equivalent between the two antibiotic groups.
  • Microbiological failure occurred in four patients with Pseudomonas aeruginosa.
  • Three patients receiving cefmetazole experienced prothrombin time prolongation.

Conclusions:

  • Cefmetazole and cefoxitin are effective and well-tolerated single agents for intra-abdominal infections.
  • Potential for prothrombin time prolongation with cefmetazole warrants consideration.
  • Further investigation may be needed for specific pathogens like Pseudomonas aeruginosa.

Related Concept Videos